Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 28, 2020
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
[ Tue, Apr 28th 2020
] - WOPRAI
Edward White Maintained (SNDX) at Strong Buy with Increased Target to $19 on, Apr 28th, 2020
Edward White of HC Wainwright & Co., Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $18 to $19 on, Apr 28th, 2020.
Edward has made no other calls on SNDX in the last 4 months.
There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebowitz of "Morgan Stanley" Maintained at Hold with Increased Target to $10 on, Wednesday, March 11th, 2020
This is the rating of the analyst that currently disagrees with Edward
- Peter Lawson of "Barclays" Initiated at Buy and Held Target at $15 on, Wednesday, March 4th, 2020
